help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, G. D.
Right arrow Articles by Davis, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, G. D.
Right arrow Articles by Davis, P. B.

Am. J. Respir. Crit. Care Med., Vol 152, No. 1, Jul 1995, 169-173.

Progression of pulmonary disease after disappearance of Pseudomonas in cystic fibrosis

GD Sharma, MF Tosi, RC Stern and PB Davis
Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, Ohio 44106, USA.

Once cystic fibrosis (CF) patients become chronically colonized, eradication of Pseudomonas aeruginosa (PA) is rare. We report five patients, each colonized for at least 6 yr, whose subsequent cultures did not reveal PA or any other gram-negative pathogen for at least 2 yr. Two patients harbored yeast, normal throat flora, and occasional colonies of Aspergillus fumigatus, but no PA, Haemophilus influenzae, or other gram-negative pathogens. In two patients, sputum cultures revealed Staphylococcus aureus. Sputum smear showed no gram-negative organisms in any patient. Antipseudomonal antibody titers in all patients decreased during the noncolonized period. However, titers increased in four other CF patients who had continued PA colonization. Despite disappearance of PA, four of five patients had clinical progression of lung disease with deterioration of FEV1. We conclude that (1) PA, even after it has chronically colonized the airways of CF patients, can occasionally disappear; and (2) lung disease can progress despite the disappearance of PA. Thus, the elimination of a milieu favorable to PA, such as might be anticipated with therapy directed at the basic defect, may not be sufficient to halt the pulmonary disease progression in CF.


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
S. M. Moskowitz, J. M. Foster, J. C. Emerson, R. L. Gibson, and J. L. Burns
Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection
J. Antimicrob. Chemother., November 1, 2005; 56(5): 879 - 886.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. J. Day, A. M. van Heeckeren, E. Min, and L. W. Velsor
Role for Cystic Fibrosis Transmembrane Conductance Regulator Protein in a Glutathione Response to Bronchopulmonary Pseudomonas Infection
Infect. Immun., April 1, 2004; 72(4): 2045 - 2051.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. S. ARMSTRONG, K. GRIMWOOD, J. B. CARLIN, R. CARZINO, J. P. GUTIERREZ, J. HULL, A. OLINSKY, E. M. PHELAN, C. F. ROBERTSON, and P. D. PHELAN
Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1197 - 1204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008